Original Research
Published on 26 Apr 2021
Identifying Genomic Alterations in Small Cell Lung Cancer Using the Liquid Biopsy of Bronchial Washing Fluid
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.647216
- 2,904 views
- 4 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,539 articles
Articles
Original Research
Published on 23 Apr 2021
Combined Analysis of RNA Sequence and Microarray Data Reveals a Competing Endogenous RNA Network as Novel Prognostic Markers in Malignant Pleural Mesothelioma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.615234
- 3,607 views
- 7 citations
Original Research
Published on 22 Apr 2021
Nivolumab and Hypofractionated Radiotherapy in Patients With Advanced Lung Cancer: ABSCOPAL-1 Clinical Trial
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.657024
- 3,332 views
- 18 citations
Review
Published on 22 Apr 2021
Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.671799
- 8,007 views
- 11 citations
Original Research
Published on 22 Apr 2021
An Immune-Related lncRNA Expression Profile to Improve Prognosis Prediction for Lung Adenocarcinoma: From Bioinformatics to Clinical Word
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.671341
- 3,367 views
- 13 citations
General Commentary
Published on 22 Apr 2021
Commentary: Overall Survival in Heart Disease–Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.639042
- 1,540 views
Original Research
Published on 21 Apr 2021
Development and Validation a Nomogram Incorporating CT Radiomics Signatures and Radiological Features for Differentiating Invasive Adenocarcinoma From Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma Presenting as Ground-Glass Nodules Measuring 5-10mm in Diameter
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.618677
- 4,447 views
- 20 citations
Review
Published on 21 Apr 2021
Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low‐Dose Computed Tomography
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.555331
- 6,770 views
- 14 citations
Original Research
Published on 20 Apr 2021
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.641975
- 3,949 views
- 4 citations
Original Research
Published on 20 Apr 2021
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.670483
- 3,881 views
- 13 citations
Original Research
Published on 20 Apr 2021
Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case Series
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.633522
- 4,150 views
- 12 citations
Original Research
Published on 19 Apr 2021
Primary Tumor Resection Improves Survival for EGFR-TKI-Treated Patients With Occult M1a Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.622723
- 2,340 views
- 2 citations
Original Research
Published on 16 Apr 2021
Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.644426
- 4,177 views
- 18 citations
Original Research
Published on 16 Apr 2021
Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.671228
- 5,150 views
- 25 citations
Original Research
Published on 16 Apr 2021
Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle Aspirates
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.584896
- 2,574 views
- 5 citations
Review
Published on 15 Apr 2021
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.650293
- 18,735 views
- 34 citations